Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
American Shared Hospital Services stock logo
AMS
American Shared Hospital Services
$2.44
+0.8%
$2.51
$2.27
$3.59
$15.88M0.3112,144 shs3,975 shs
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
$5.13
-3.7%
$5.54
$4.59
$14.36
$9.84M0.914,930 shs10,208 shs
CME Group Inc. stock logo
CME
CME Group
$259.73
+0.3%
$273.13
$212.38
$290.79
$93.61B0.432.29 million shs771,137 shs
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
American Shared Hospital Services stock logo
AMS
American Shared Hospital Services
-2.81%-3.20%-7.63%+2.11%-9.70%
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
+1.93%+2.52%+2.52%-6.38%-56.63%
CME Group Inc. stock logo
CME
CME Group
-1.32%-1.43%-5.51%-4.03%+19.28%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
American Shared Hospital Services stock logo
AMS
American Shared Hospital Services
$2.44
+0.8%
$2.51
$2.27
$3.59
$15.88M0.3112,144 shs3,975 shs
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
$5.13
-3.7%
$5.54
$4.59
$14.36
$9.84M0.914,930 shs10,208 shs
CME Group Inc. stock logo
CME
CME Group
$259.73
+0.3%
$273.13
$212.38
$290.79
$93.61B0.432.29 million shs771,137 shs
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
American Shared Hospital Services stock logo
AMS
American Shared Hospital Services
-2.81%-3.20%-7.63%+2.11%-9.70%
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
+1.93%+2.52%+2.52%-6.38%-56.63%
CME Group Inc. stock logo
CME
CME Group
-1.32%-1.43%-5.51%-4.03%+19.28%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
American Shared Hospital Services stock logo
AMS
American Shared Hospital Services
0.00
N/AN/AN/A
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
2.33
Hold$47.50826.83% Upside
CME Group Inc. stock logo
CME
CME Group
2.06
Hold$260.600.33% Upside

Current Analyst Ratings Breakdown

Latest BOLT, AMS, and CME Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/8/2025
CME Group Inc. stock logo
CME
CME Group
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetNeutral$305.00 ➝ $285.00
8/15/2025
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
Lake Street Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$75.00
7/24/2025
CME Group Inc. stock logo
CME
CME Group
Oppenheimer
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$300.00 ➝ $303.00
7/24/2025
CME Group Inc. stock logo
CME
CME Group
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price TargetEqual Weight$299.00 ➝ $298.00
7/24/2025
CME Group Inc. stock logo
CME
CME Group
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuyNeutral$305.00
7/15/2025
CME Group Inc. stock logo
CME
CME Group
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$283.00 ➝ $296.00
7/10/2025
CME Group Inc. stock logo
CME
CME Group
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetEqual Weight$283.00 ➝ $299.00
7/3/2025
CME Group Inc. stock logo
CME
CME Group
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$265.00 ➝ $275.00
(Data available from 9/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
American Shared Hospital Services stock logo
AMS
American Shared Hospital Services
$28.34M0.56$0.87 per share2.81$4.68 per share0.52
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
$7.69M1.28N/AN/A$29.89 per share0.17
CME Group Inc. stock logo
CME
CME Group
$6.13B15.27$11.22 per share23.14$73.66 per share3.53
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
American Shared Hospital Services stock logo
AMS
American Shared Hospital Services
$2.19M$0.60N/A8.13N/A-8.27%-8.07%-3.87%11/12/2025 (Estimated)
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
-$63.12M-$26.66N/AN/AN/AN/A-91.67%-53.19%11/11/2025 (Estimated)
CME Group Inc. stock logo
CME
CME Group
$3.53B$10.3325.1523.634.7558.48%14.60%2.61%10/22/2025 (Estimated)

Latest BOLT, AMS, and CME Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2025Q2 2025
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
-$6.40-$4.46+$1.94-$4.46$0.82 million$1.80 million
7/23/2025Q2 2025
CME Group Inc. stock logo
CME
CME Group
$2.91$2.96+$0.05$2.81$1.68 billion$1.69 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
American Shared Hospital Services stock logo
AMS
American Shared Hospital Services
N/AN/AN/AN/AN/A
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
N/AN/AN/AN/AN/A
CME Group Inc. stock logo
CME
CME Group
$5.001.93%N/A48.40%N/A

Latest BOLT, AMS, and CME Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/7/2025
CME Group Inc. stock logo
CME
CME Group
quarterly$1.251.91%9/9/20259/9/20259/25/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
American Shared Hospital Services stock logo
AMS
American Shared Hospital Services
0.32
1.17
1.17
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
0.56
3.11
3.11
CME Group Inc. stock logo
CME
CME Group
0.12
1.02
1.02

Institutional Ownership

CompanyInstitutional Ownership
American Shared Hospital Services stock logo
AMS
American Shared Hospital Services
23.16%
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
86.70%
CME Group Inc. stock logo
CME
CME Group
87.75%

Insider Ownership

CompanyInsider Ownership
American Shared Hospital Services stock logo
AMS
American Shared Hospital Services
23.80%
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
30.90%
CME Group Inc. stock logo
CME
CME Group
0.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
American Shared Hospital Services stock logo
AMS
American Shared Hospital Services
106.51 million4.96 millionNot Optionable
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
901.92 million1.33 millionNot Optionable
CME Group Inc. stock logo
CME
CME Group
3,760360.38 million359.30 millionOptionable

Recent News About These Companies

2,863 Shares in CME Group Inc. $CME Acquired by Dover Advisors LLC
CME Group: The Bull Case Remains Compelling
CME Group: A Great Business, But Not At A Cheap Enough Price
Rep. Julie Johnson Purchases Shares of CME Group Inc. (NASDAQ:CME)
Why the success of electrification relies on battery metals
Invst LLC Buys New Holdings in CME Group Inc. $CME
Swedbank AB Grows Stock Position in CME Group Inc. $CME
Bitcoin Derivatives Heat up as CME Leads, Options Lean Call-Heavy
Strs Ohio Makes New Investment in CME Group Inc. $CME
Woodline Partners LP Grows Stock Holdings in CME Group Inc. $CME

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
American Shared Hospital Services stock logo

American Shared Hospital Services NYSEAMERICAN:AMS

$2.44 +0.02 (+0.83%)
As of 01:28 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

American Shared Hospital Services provides stereotactic radiosurgery and advanced radiation therapy equipment. It operates in two segments, Medical Equipment Leasing, and Retail. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia. It also provides financing services for Leksell Gamma Knife units; and leases medical equipment. In addition, the company offers proton beam radiation therapy services in Orlando, Florida and Long Beach, California, as well as offers planning, installation, reimbursement, and marketing support services to its customers. The company markets its solutions to cancer treatment centers, hospitals, and cancer networks worldwide. American Shared Hospital Services was founded in 1980 and is based in San Francisco, California.

Bolt Biotherapeutics stock logo

Bolt Biotherapeutics NASDAQ:BOLT

$5.12 -0.20 (-3.67%)
As of 01:17 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company's lead product candidate BDC-1001, which is in clinical development for the treatment of patients with human epidermal growth factor receptor 2- positive solid tumors, including breast, colorectal, endometrial, and gastroesophageal cancer. It is also developing BDC-3042, an agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer. The company has collaboration agreements with Toray Industries, Genmab A/S, Innovent Biologics, Inc., Bristol-Myers Squibb, and F. Hoffmann-La Roche Ltd; and license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California.

CME Group stock logo

CME Group NASDAQ:CME

$259.73 +0.90 (+0.35%)
As of 01:33 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. The company was founded in 1898 and is headquartered in Chicago, Illinois.